home / stock / verv / verv articles

VERV Articles, Verve Therapeutics Inc.

Stock Information
Company Name: Verve Therapeutics Inc.
Stock Symbol: VERV
Market: NASDAQ
Website: vervetx.com
Menu
VERV VERV Quote VERV Short VERV News VERV Articles VERV Message Board
Get VERV Alerts

News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors | Benzinga

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of ca...
Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Drops Below Key $62K Level | Benzinga

On Monday, Cathie Wood-led Ark Invest made some significant trades, with Coinbase Global Inc. (NASDAQ:COIN) taking the spotlight. This comes amidst...

Cathie Wood-Led Ark Invest Sells $1.5M Worth Of Robinhood Shares Amid Muted Bitcoin Market — Also Dumps Zoom Stock Worth $3.3M | Benzinga

Ark Invest, led by Cathie Wood, made significant trades on Wednesday involving Robinhood Markets Inc (NASDAQ:HOOD) and Zoom Video Communications In...

Verve Therapeutics Announces Leadership Update | Benzinga

Troy Lister, Ph.D., to be promoted to chief scientific officer Andrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory cap...
Verve Therapeutics to Participate in Upcoming Investor Conferences | Benzinga

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of car...

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF | Benzinga

Cathie Wood‘s flagship ARK Innovation ETF (NYSE:ARKK) has been navigating through significant losses, showcasing the challenges faced by some...

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results | Benzinga

First patient dosed in Heart-2 Phase 1b clinical trial of VERVE-102 VERVE-201 clinical trial initiation on track for the second half of 2024 Recei...
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter | Benzinga

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...

Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade | Benzinga

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s p...

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More | Benzinga

Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of c...
Next 10